Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (stock code: 600196.SH, 02196.HK), founded in 1994, is a leading and innovation-driven international pharmaceutical and healthcare industry group in China. Its business fields are strategically arranged in pharmaceutical manufacturing, medical devices, medical diagnostics, and healthcare services, and it also covers the pharmaceutical distribution and retail business field as a shareholder of Sinopharm Co., Ltd.
Investor Relations Contact Email:ir@fochon.com.cn
Shanghai Fosun Pharma (Group) Co., Ltd. (stock code: 600196.SH, 02196.HK), established in 1994, is a leading, innovation-driven international pharmaceutical and health industry group in China, with a strategic layout of the pharmaceutical and health industry chain in its business areas. , the directly operating business includes pharmaceuticals, medical devices and medical diagnosis, medical services, and covers the pharmaceutical business field through participation in Sinopharm Holding.
Investor Relations Contact Email:ir@fochon.com.cn
Shanghai Fosun Pharma (Group) Co., Ltd. (stock code: 600196.SH, 02196.HK), established in 1994, is a leading, innovation-driven international pharmaceutical and health industry group in China, with a strategic layout of the pharmaceutical and health industry chain in its business areas. , the directly operating business includes pharmaceuticals, medical devices and medical diagnosis, medical services, and covers the pharmaceutical business field through participation in Sinopharm Holding.
Investor Relations Contact Email:ir@fochon.com.cn